MAMohammad Alqahtani

Mohammad Alqahtani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad Alqahtani has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Abdelmajeed Alanazi

    Department of Neurology, King Saud Medical City, Riyadh, Saudi Arabia

    1 shared publication
  • Abdullah Alrashed

    Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    1 shared publication
  • Abdulrahman A Alreshaid

    Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    1 shared publication
  • Adel AlHazzani

    Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    1 shared publication
  • Alaa Hijji

    Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    1 shared publication
  • Ammar AlKawi

    Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

    1 shared publication

Latest Publications

  • Adjunctive intra-arterial thrombolysis after thrombectomy: Findings from the RITE registry

    by Samar Eshetawe, Alaa Hijji, Sarah Almejaiwl, Mohammad Alqahtani, Fawaz F Alotaibi, Saida Mohammad, Hani Alabdely, Abdelmajeed Alanazi, Nouf Almansour, Abdullah Alrashed, et al.

    Background: Despite the excellent recanalization rates following thrombectomy, significantly fewer patients have favorable outcomes. Impaired reperfusion of the microcirculation caused by distal thrombi could contribute to that, and adjunctive intraarterial thrombolysis such as alteplase (IA-tPA) might improve outcomes. We assessed the impact of adjunctive IA-tPA following thrombectomy with TICI score ≥ 2A on functional outcomes and reperfusion status. Methods: A retrospective analysis of patients with LVO ischemic stroke who underwent EVT. Patients were dichotomized into those who received EVT + IA-tPA vs EVT alone. Primary outcomes were favorable functional outcome (90-day mRS 0–2), and 90-day home-time. Results: 354 patients were included, of which 133 (37.6%) were treated with EVT + IA-tPA and 221 (62.4%) were treated with EVT alone. Baseline characteristics were similar in both groups. The non-IA-tPA group had a significant proportion of patients with higher baseline TICI scores (P < 0.0001). There was no significant difference in the rate of favorable functional outcomes between patients who received IA-tPA vs those who did not (59.8% vs 66.1%; p = 0.27), 90-day home time was 77 (69–83) vs 66 (60–81) days, p = 0.26. There was no difference in the rate of sICH (2.2% vs 2.3%; P = 0.99), and mortality (15% vs 8.3%; P = 0.06). IA-tPA resulted in a significant improvement in TICI scores from 33.3% to 62.9% and was 3.4 times more likely to improve reperfusion status. Conclusion: IA-tPA following thrombectomy with TICI score ≥ 2A appeared to be safe and improved the final TICI score; however, this angiographic improvement did not translate into functional outcomes.